Ayalon Insurance Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.44M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $263K | Hold |
|
|||||
|
2021
Q3 | $296K | Sell |
|
|||||
|
2021
Q2 | $884K | Sell |
|
|||||
|
2021
Q1 | $1.72M | Buy |
|
|||||
|
2020
Q4 | $1.76M | Hold |
|
|||||
|
2020
Q3 | $1.4M | Sell |
|
|||||
|
2020
Q2 | $1.74M | Buy |
|
|||||
|
2020
Q1 | $49K | Hold |
|
|||||
|
2019
Q4 | $64K | Sell |
|
|||||
|
2019
Q3 | $56K | Sell |
|
|||||
|
2019
Q2 | $119K | Hold |
|
|||||
|
2019
Q1 | $122K | Sell |
|
|||||
|
2018
Q4 | $107K | Sell |
|
|||||
|
2018
Q3 | $1.3M | Sell |
|
|||||
|
2018
Q2 | $2.33M | Buy |
|
|||||
|
2018
Q1 | $1.42M | Buy |
|
|||||
|
2017
Q4 | $1.34M | Buy |
|